Discover more from Dead Man Talking
Mortality in Japan 2010 to 2022 - the price of mass compliance
Logical analysis and Occam's razor indicates that the mRNA experiment is associated with significant loss of life.
Japan is a compliant nation of people, achieving way above average COVID “vaccination” rates compared to the rest of the world and the rest of Asia too.
But it’s strange that they would be so zealously compliant to “protect” themselves from a disease that had absolutely no excess mortal impact (prior to the nationwide compromise of immunity as a result of the mRNA experiment).
In fact, as can be clearly seen in Figure 2, immediately after the COVID “epidemic” in 2020, Japan had the most significant period of seasonal deficit mortality in ten years (point A) after no excess mortality whatsoever.
And yet, in the aftermath of the mass mRNA experiment (to protect them against a virus/disease that they did not need protection from), they have experienced higher seasonal excess and lower seasonal deficit ever since.
Just look at the change in slope of the trend line! (Green pre-COVID, red post vax).
In 2020, the year of the COVID epidemic, Japan had the lowest “super excess”1 mortality for ten years (Figure 3). Some epidemic, huh?
In 2021, when the mRNA experiment began, “super excess” mortality returns to the usual range.
In 2022, it is two to three times higher than usual… Go figure!
It is a similar picture when looking at "seasonal excess"2 (Figure 4).
Perhaps most alarming (unless you are in public office) is the dramatic rise in the “baseline” or level of “seasonal deficit mortality”3 (Figure 5).
Prior to the “vaccination” campaign, the seasonal deficit mortality averaged just over 45k. In 2022, it was just 17k4 (Figure 2, point B), with both 2021 and 2022 being the only two years since 2011 having baselines higher than the low end of the range trend5 (Figure 2, red arrows).
In terms of “net deficit”6 (Figure 6), once again 2022 has seen a substantial rise above normal levels, at around four times recent years, after 2020 (the year of the COVID “epidemic”) had bucked the recent trend, coming in substantially lower.
So, after a year of below normal mortality during the alleged epidemic, measured both in terms of seasonal excess and baseline and adjusted for upward trending mortality, Japan is now experiencing by far the worst mortality outcomes in recent times.
Must be the missed statins prescriptions?
Source data: Ministry of Health, Labor and Welfare of Japan
“Super excess” is defined as deaths that lie more than 1 standard deviation above the 10-year trend up to the start of the COVID “epidemic”.
“Seasonal excess” is defined as all deaths that lie above the trend line. Mortality follows a distinctly seasonal pattern in Japan, always peaking in late Jan / early Feb (with the notable exception of Mar 2011).
“Seasonal deficit mortality“ is defined as deaths that lie below the trend line. The “baseline” is establish as the low point each year, which is almost always mid-July.
For those that do stats, that’s a 3-sigma event, i.e. 1 in 100 chance of happening by chance.
The range trend is set +/- 1 standard deviation.
“Net deficit“ is defined as the sum of seasonal excess and seasonal deficit.